Isaac Blech
Founder chez X-Vax Technology, Inc.
Profil
Isaac Blech is the founder of Avalo Therapeutics, Inc. (founded in 2011), Sapience Therapeutics, Inc. (founded in 2015), and Elucida Oncology, Inc. (founded in 2014).
He held the title of Vice Chairman at Avalo Therapeutics, Inc. from 2012 to 2019, at Sapience Therapeutics, Inc., and at Elucida Oncology, Inc. Mr. Blech was also the founder of Celgene Corp., PathoGenesis Corp, ICOS Corp., Nova Pharmaceutical Corp., Genetic Systems Corp., X-Vax Technology, Inc., Nacuity Pharmaceuticals, Inc. Mr. Blech previously held the position of Vice Chairman at Alveo Health LLC, Alveo Technologies, Inc., and Director at Regenovation, Inc. He is also a Trustee at River Charitable Remainder Unitrust F.Mr. Blech has held former positions as Vice Chairman at root9B Holdings, Inc. from 2011 to 2017, at Edge Therapeutics, Inc., Centrexion Therapeutics Corp., X4 Pharmaceuticals, Inc., Aridis Pharmaceuticals, Inc., SpendSmart Networks, Inc. from 2011 to 2020, at InspireMD, Inc. from 2016 to 2017, at WaveGuide Corp., at RestorGenex Corp.
from 2013 to 2016, at Diffusion Pharmaceuticals, Inc. from 2016 to 2018, and as Director at Arsanis, Inc. and Elicio Therapeutics, Inc. (Old).
He also served as an Independent Director at Aevi Genomic Medicine, Inc. from 2011 to 2017, at ContraFect Corp.
from 2010 to 2019, at CNS, Inc., at Adhera Therapeutics, Inc. from 2017 to 2019, and as a Director at X4 Pharmaceuticals, Inc. from 2015 to 2019.
Mr. Blech obtained his undergraduate degree from Baruch College in 1975.
Mr. Blech is also the founder of Celgene Corp., PathoGenesis Corp, ICOS Corp., Nova Pharmaceutical Corp., Genetic Systems Corp., X-Vax Technology, Inc., Nacuity Pharmaceuticals, Inc...
Postes actifs de Isaac Blech
| Sociétés | Poste | Début |
|---|---|---|
| River Charitable Remainder Unitrust F/B/O Isaac Blech | Director/Board Member | - |
Regenovation, Inc.
 Regenovation, Inc. Miscellaneous Commercial ServicesCommercial Services Regenovation, Inc. develops ways to regenerate human tissue. The company is headquartered in New York, NY. | Director/Board Member | - |
| Alveo Health LLC | Director/Board Member | - |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Founder | 01/01/2015 |
Alveo Technologies, Inc.
 Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Director/Board Member | - |
Anciens postes connus de Isaac Blech
| Sociétés | Poste | Fin |
|---|---|---|
| SPENDSMART NETWORKS, INC. | Director/Board Member | 14/08/2020 |
| ADHERA THERAPEUTICS, INC. | Director/Board Member | 19/12/2019 |
| X4 PHARMACEUTICALS, INC. | Director/Board Member | 17/06/2019 |
| CONTRAFECT CORPORATION | Director/Board Member | 22/05/2019 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Formation de Isaac Blech
| Baruch College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| ROOT9B HOLDINGS, INC. | Technology Services |
| CONTRAFECT CORPORATION | Health Technology |
| INSPIREMD, INC. | Health Technology |
| AVALO THERAPEUTICS, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| ARIDIS PHARMACEUTICALS, INC. | Health Technology |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 24 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a private company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
| River Charitable Remainder Unitrust F/B/O Isaac Blech | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
Centrexion Therapeutics Corp.
 Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA. | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
| Nova Pharmaceutical Corp. | |
| Genetic Systems Corp. | |
SpendSmart Networks, Inc.
 SpendSmart Networks, Inc. Advertising/Marketing ServicesCommercial Services SpendSmart Networks, Inc. engages in the provision of mobile and loyalty marketing agency services. It operates under the SMS Masterminds brand. It offers licenses, which includes a proprietary software as a service system, proprietary marketing, and sales training materials; and mobile responsive website building software. The company was founded by Alex Minicucci and Luke Wallace on May 14, 1990 and is headquartered in San Luis Obispo, CA. | Commercial Services |
| CNS, Inc. | Miscellaneous |
WaveGuide Corp.
 WaveGuide Corp. Medical SpecialtiesHealth Technology Waveguide Corp. operates as an analytical instrument company. The firm develops medical and industrial diagnostic devices with core expertise in three domains: custom ASICs; embedded systems & algorithms; and customized, functionalized magnetic nanoparticles. It focuses on developing its portable micro-nuclear magnetic resonance (µNMR) platform technology. The company was founded by Marcus Semones in 2015 and is headquartered in Cambridge, MA. | Health Technology |
RestorGenex Corp.
 RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Health Technology |
Regenovation, Inc.
Regenovation, Inc. Miscellaneous Commercial ServicesCommercial Services Regenovation, Inc. develops ways to regenerate human tissue. The company is headquartered in New York, NY. | Commercial Services |
Diffusion Pharmaceuticals, Inc.
 Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. | Health Technology |
Sapience Therapeutics, Inc.
 Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | Health Technology |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Health Technology |
Nacuity Pharmaceuticals, Inc.
 Nacuity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nacuity Pharmaceuticals, Inc. develops and markets pharmaceutical products. The company is headquartered in Fort Worth, TX. | Health Technology |
| Alveo Health LLC | |
Alveo Technologies, Inc.
Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Health Technology |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Health Technology |
